CRAB is the Data Center for the SWOG Statistical Center. Not only is SWOG by far our largest customer, it is through that relationship that our products, services and expertise have been honed.
CRAB has long standing partnerships with other research consortia which have provided opportunities to expand our expertise beyond clinical trials. We have refined and improved cancer staging for myeloma and lung cancer through our relationship with International Myeloma Foundation and International Association for the Study of Lung Cancer, respectively. Our ongoing work with Myeloma Institute for Research and Therapy is rich with some of the earliest use of genomic analyses in the clinical trial arena, producing prognostic and predictive marker that continue to be refined for clinical use. Similarly, as the statistical center for the SU2C Pancreatic Dream team and Pancreatic Cancer Research Team we are working with collaborators to combine translational data to improve clinical outcomes.
CRAB’s Clinical Research Services (CRS) division looks to expand the number of key partnerships we have in place with research consortia as well as pharmaceutical clients. As we continue to build and leverage our oncology expertise, we believe our client-centric approach will help us to strengthen and expand our key research partnerships.
CRAB’s CEO, John Crowley, is collaborating with a select number of executives to address significant, and often very similar, challenges related to the generation of grant revenue, research and development, collaborating with industry, and other institutional administrative matters. The Pacific Northwest Life Sciences Executive Forum was created to bring together executive level professionals from non-profit life sciences organizations in the Pacific Northwest to mutually discuss these shared challenges, share best practices, and determine areas for potential inter-institutional or regional collaboration.